Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2020 Aug 31:2020:2398721.
doi: 10.1155/2020/2398721. eCollection 2020.

Bilateral Basal Ganglion Hemorrhage after Severe Olanzapine Intoxication

Affiliations
Case Reports

Bilateral Basal Ganglion Hemorrhage after Severe Olanzapine Intoxication

Kerstin Schweyer et al. Case Rep Psychiatry. .

Abstract

Olanzapine is a second-generation antipsychotic drug which is generally considered safe with well therapeutic antipsychotic effects. We describe a patient suffering from bilateral intracerebral hemorrhage after severe olanzapine intoxication without underlying thrombocytopenia, arterial hypertension, or vascular malformation as cause of intracerebral hemorrhage. This raises the possibility of a direct side effect of high-dose olanzapine intake. So far, intracranial hemorrhage after olanzapine intoxication in such constellation has not been reported before. Given the high number of its prescription rates, our finding of intracranial hemorrhage after olanzapine intoxication is of high clinical relevance.

PubMed Disclaimer

Conflict of interest statement

The authors declare that there is no conflict of interest regarding the publication of this article.

Figures

Figure 1
Figure 1
(a) Day 0. Initial CT scan presenting left-hemispheric intracranial hemorrhage in typical localization. (b) Day 2. MRI scan (SWI sequence) illustrating bilateral ICH corresponding to the CT scan. No microbleeds were detected. (c) Day 4. Progressive bilateral intracranial hemorrhage. (d). Day 4. CT scan after hemicraniectomy.

Similar articles

Cited by

References

    1. Mauri M. C., Paletta S., Maffini M., et al. Clinical pharmacology of atypical antipsychotics: an update. EXCLI Journal. 2014;13:1163–1191. - PMC - PubMed
    1. Simpson G. M., Glick I. D., Weiden P. J., Romano S. J., Siu C. O. Randomized, controlled, double-blind multicenter comparison of the efficacy and tolerability of ziprasidone and olanzapine in acutely ill inpatients with schizophrenia or schizoaffective disorder. The American Journal of Psychiatry. 2004;161(10):1837–1847. doi: 10.1176/ajp.161.10.1837. - DOI - PubMed
    1. Petersen A. B., Andersen S. E., Christensen M., Larsen H. L. Adverse effects associated with high-dose olanzapine therapy in patients admitted to inpatient psychiatric care. Clinical Toxicology (Philadelphia, Pa.) 2014;52(1):39–43. doi: 10.3109/15563650.2013.862258. - DOI - PubMed
    1. Chue P., Singer P. A review of olanzapine-associated toxicity and fatality in overdose. Journal of Psychiatry & Neuroscience. 2003;28(4):253–261. - PMC - PubMed
    1. Lennestal R., Asplund C., Nilsson M., Lakso H. A., Mjorndal T., Hagg S. Serum levels of olanzapine in a non-fatal overdose. Journal of Analytical Toxicology. 2007;31(2):119–121. doi: 10.1093/jat/31.2.119. - DOI - PubMed

Publication types

LinkOut - more resources